In the second part of their article on the emerging field of neuroimmu
nology, the authors present an overview of the role of neuroimmune mec
hanisms in defence against infectious diseases and in immune disorders
. During acute febrile illness, immune-derived cytokines initiate an a
cute phase response, which is characterized by fever, inactivity, fati
gue, anorexia and catabolism. Profound neuroendocrine and metabolic ch
anges take place: acute phase proteins,are produced in the liver, bone
marrow function and the metabolic activity of leukocytes are greatly
increased, and specific immune reactivity is suppressed. Defects in re
gulatory processes, which are fundamental to immune disorders land inf
lammatory diseases, may lie in the immune system, the neuroendocrine s
ystem or both. Defects in the hypothalamus-pituitary-adrenal axis have
been observed in autoimmune and rheumatic diseases, chronic inflammat
ory disease, chronic fatigue syndrome and fibromyalgia. Prolactin leve
ls are often elevated in patients with systemic lupus erythematosus an
d other autoimmune diseases, whereas the bioactivity of prolactin is d
ecreased in patients with rheumatoid arthritis. Levels of sex hormones
and thyroid hormone are decreased during severe inflammatory disease.
Defective neural regulation of inflammation likely plays a pathogenic
role in allergy and asthma, in the symmetrical form of rheumatoid art
hritis and in gastrointestinal inflammatory disease. A better understa
nding of neuroimmunoregulation holds the promise of neu approaches to
the treatment of immune and inflammatory diseases with the use of horm
ones, neurotransmitters, neuropeptides and drugs that modulate these n
ewly recognized immune regulators.